Functional decline associated with polypharmacy and potentially inappropriate medications in community-dwelling older adults with dementia.
This study provides empirical evidence on whether polypharmacy and potentially inappropriate prescription medications (PIRx, as defined by the 2003 Beers criteria) increase the likelihood of functional decline among community-dwelling older adults with dementia. Data were from the National Alzheimer's Coordinating Center, Uniform Data Set (9/2005-9/2009). Study sample included 1994 community-dwelling participants aged ≥65 with dementia at baseline. Results showed that participants having ≥5 medications were more likely to have functional decline than participants having <5 medications. However, the increased likelihood was only apparent in participants who did not have PIRx. Instead of magnifying the associated risk as hypothesized, PIRx appeared to have a protective effect albeit marginally statistically significant. Therefore, increased medication burden may be associated with functional decline in community-dwelling older adults with dementia who are not prescribed with PIRx. More research is needed to understand which classes of medications have the most deleterious effect on this population.
Department of Pharmacy Administration, University of Illinois at Chicago, College of Pharmacy, 60612, USA. DTLau@uic.edu
Denys T
DT
Lau
Nathaniel D
ND
Mercaldo
Joseph W
JW
Shega
Alfred
A
Rademaker
Sandra
S
Weintraub
D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000188:drug therapy*; D003704:Dementia / Q000188:drug therapy*; D011307:Drug Prescriptions; D004363:Drug Utilization; D005260:Female; D006801:Humans; D057970:Inappropriate Prescribing; D008297:Male; D019338:Polypharmacy; D012111:Residence Characteristics; D012306:Risk